Your browser doesn't support javascript.
loading
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.
Bahri, Priya; Bowring, Geoffrey; Edwards, Brian D; Anton, Christopher; Aronson, Jeffrey K; Caro-Rojas, Angela; Hugman, Bruce P J; Mol, Peter G; Trifirò, Gianluca; Ilic, Katarina; Daghfous, Riadh; Fermont, Irene; Furlan, Giovanni; Gaissmaier, Wolfgang; Geer, Mohammad Ishaq; Hartigan-Go, Kenneth Y; Houÿez, François; Neth, Hansjörg; Norgela, Gediminas; Oppamayun, Yaowares; Raynor, D K Theo; Bouhlel, Mehdi; Santoro, Federica; Sultana, Janet.
Afiliación
  • Bahri P; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland. priya.bahri@ema.europa.eu.
  • Bowring G; European Medicines Agency (EMA) (Coordinator of the ISoP CommSIG in Her Personal Capacity), Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands. priya.bahri@ema.europa.eu.
  • Edwards BD; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
  • Anton C; Uppsala Monitoring Centre (UMC), Uppsala, Sweden.
  • Aronson JK; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
  • Caro-Rojas A; Husoteria Ltd, Ashtead, UK.
  • Hugman BPJ; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
  • Mol PG; West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK.
  • Trifirò G; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Oxford, UK.
  • Ilic K; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
  • Daghfous R; Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Fermont I; , Oxford, UK.
  • Furlan G; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
  • Gaissmaier W; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands.
  • Geer MI; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Hartigan-Go KY; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
  • Houÿez F; Takeda, Cambridge, MA, USA.
  • Neth H; Tunisian National Centre of Pharmacovigilance, Tunis, Tunisia.
  • Norgela G; Israel Society for Medication and Vaccine Safety (ERANIM), Jerusalem, Israel.
  • Oppamayun Y; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
  • Raynor DKT; Pfizer s.r.l., Safety Surveillance and Risk Management, Milan, Italy.
  • Bouhlel M; Department of Psychology, Social Psychology and Decision Sciences, University of Konstanz, Konstanz, Germany.
  • Santoro F; Department of Pharmaceutical Sciences, University of Kashmir, Srinagar, India.
  • Sultana J; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
Drug Saf ; 46(6): 517-532, 2023 06.
Article en En | MEDLINE | ID: mdl-37219785
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Farmacovigilancia Límite: Humans Idioma: En Revista: Drug Saf Asunto de la revista: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Farmacovigilancia Límite: Humans Idioma: En Revista: Drug Saf Asunto de la revista: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza